<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/"><channel><title>PeptideScanner evidence for Larazotide</title><link>https://peptidescanner.com/peptides/larazotide/</link><description>Versioned, source-linked PeptideScanner evidence objects for Larazotide. Selected coverage; not medical advice.</description><language>en-us</language><atom:link href="https://peptidescanner.com/feeds/peptides/larazotide.xml" rel="self" type="application/rss+xml"/><item><title>ClinicalTrials.gov record NCT00362856</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct00362856-larazotide/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct00362856-larazotide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/larazotide.json#clinicaltrials-gov-nct00362856-larazotide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2017-09-12. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT00386165</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct00386165-larazotide/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct00386165-larazotide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/larazotide.json#clinicaltrials-gov-nct00386165-larazotide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2017-09-11. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT00386490</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct00386490-larazotide/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct00386490-larazotide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/larazotide.json#clinicaltrials-gov-nct00386490-larazotide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2017-09-12. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT00492960</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct00492960-larazotide/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct00492960-larazotide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/larazotide.json#clinicaltrials-gov-nct00492960-larazotide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2017-09-20. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT00620451</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct00620451-larazotide/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct00620451-larazotide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/larazotide.json#clinicaltrials-gov-nct00620451-larazotide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2017-09-20. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT00889473</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct00889473-larazotide/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct00889473-larazotide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/larazotide.json#clinicaltrials-gov-nct00889473-larazotide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2017-09-20. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT01396213</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct01396213-larazotide/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct01396213-larazotide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/larazotide.json#clinicaltrials-gov-nct01396213-larazotide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2017-09-20. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT05747534</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct05747534-larazotide/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct05747534-larazotide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/larazotide.json#clinicaltrials-gov-nct05747534-larazotide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2026-08-18. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>Commentary: larazotide acetate - an exciting new development for coeliac patients?</title><link>https://peptidescanner.com/stories/pubmed-pmid-23336683-larazotide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-23336683-larazotide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/larazotide.json#pubmed-pmid-23336683-larazotide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2018-12-02. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Commentary: larazotide acetate - an exciting new development for coeliac patients? Authors&apos; reply.</title><link>https://peptidescanner.com/stories/pubmed-pmid-23336684-larazotide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-23336684-larazotide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/larazotide.json#pubmed-pmid-23336684-larazotide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2018-12-02. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>[Larazotide as an option in case of failure of a gluten-free diet].</title><link>https://peptidescanner.com/stories/pubmed-pmid-26983338-larazotide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-26983338-larazotide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/larazotide.json#pubmed-pmid-26983338-larazotide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2021-08-27. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Zonulin Antagonist, Larazotide (AT1001), As an Adjuvant Treatment for Multisystem Inflammatory Syndrome in Children: A Case Series.</title><link>https://peptidescanner.com/stories/pubmed-pmid-35211683-larazotide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-35211683-larazotide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/larazotide.json#pubmed-pmid-35211683-larazotide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2022-03-17. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Viral spike antigen clearance and augmented recovery in children with post-COVID multisystem inflammatory syndrome treated with larazotide.</title><link>https://peptidescanner.com/stories/pubmed-pmid-40737433-larazotide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-40737433-larazotide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/larazotide.json#pubmed-pmid-40737433-larazotide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2026-08-12. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item></channel></rss>
